跳至主要内容
临床试验/ACTRN12615001115527
ACTRN12615001115527尚未招募1 期

Randomized, Placebo-Controlled Clinical Trial of Transdermal DHT Gel to Improve IVF Outcomes In Women With Poor Ovarian Response

Prof.David Handelsman0 个研究点目标入组 242 人开始时间: 2015年10月22日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
242

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • *Age >18 years
  • *Modified Bologna criteria stratified by age
  • -For women >40 years, no additional inclusion criteria
  • -For women <40 years, at least one additional inclusion criterion either previous IVF cycle with POR (<3 oocytes with conventional stimulation) and/or impaired ovarian reserve (ultrasonic antral follicle count <7 follicles or serum AMH <1.1 ng/ml)

排除标准

  • *Use of androgens or pro-androgens in previous 2 months
  • *Perimenopausal (no regular cycle, high serum FSH)
  • *Major uterine abnormalities
  • *History of untreated systemic medical disease or organ failure (eg impaired cardiac, respiratory, hepatic, or renal function)
  • *Extensive skin disease that would interfere with use of the transdermal gel
  • *Participation in other clinical trials of medical therapy

研究者

发起方
Prof.David Handelsman

相似试验